Targeted Activation of Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Rapidly Suppresses Inflammation Through Inhibition of Toll-Like Receptor 4/Nuclear Factor-kappa B (TLR4/NF-kappa B) Pathway and Further Shifts Advanced Atheroma Into a Stable Phenotype